Desheng Weng

Spesialisasi: Clinical oncologist
Tempat kerja: China, Cantão, Sun Yat-sen University Cancer Center (SYSUCC)
Desheng Weng adalah spesialis di Sun Yat-sen University Cancer Center, menjabat sebagai Associate Professor dan Wakil Direktur di Pusat Bioterapi / Onkologi Medis Melanoma dan Sarkoma. Karyanya mencakup genetika kanker—meneliti gen penekan tumor seperti ING2, TESTIN, BATF2, LZAP, dan BIN1 pada karsinoma hepatoseluler primer dan kanker lambung—serta imunoterapi kanker sebagai pendekatan pengobatan yang komprehensif. Fokus klinis-penelitiannya meliputi melanoma dan sarkoma, serta perawatan kanker berbasis imunoterapi.
Desheng Weng adalah spesialis di Sun Yat-sen University Cancer Center, di mana ia menjabat sebagai Associate Professor dan Wakil Direktur di Pusat Bioterapi / Onkologi Medis Melanoma dan Sarkoma. Ia menggabungkan penelitian genetika kanker dengan perawatan onkologi yang berfokus pada imunoterapi. Penelitiannya mencakup studi gen penekan tumor seperti ING2, TESTIN, BATF2, LZAP, dan BIN1 serta kaitannya dengan fitur klinis pada karsinoma hepatoseluler dan kanker lambung.

Layanan dokter

Penyaringan genetik

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Kualifikasi

Desheng Weng works as a specialist at Sun Yat-sen University Cancer Center, holding the roles of Associate Professor and Deputy Director in the Biotherapy Center and Melanoma and Sarcoma Medical Oncology. His research program connects cancer genetics with immunotherapy, reflecting a biotherapy-centered approach to treating melanoma and sarcoma. In cancer genetics studies, his work includes tumor suppressor gene down-regulation and evaluating genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 in primary hepatocellular carcinoma and gastric cancer. He also investigates how these tumor suppressors relate to clinicopathological parameters and explores their functional roles through in vitro assays such as proliferation, clone formation, motility, invasion, and apoptosis of tumor cell lines. Alongside genetics, Weng’s profile highlights immunotherapy as an important comprehensive method for cancer patients. For international patients, this means he participates in a program where treatment planning is informed by both tumor biology and immunotherapy concepts.

Education

Education details are not specified in the provided profile materials.

Work experience

Associate Professor and Deputy Director, Biotherapy Center / Melanoma and Sarcoma Medical Oncology, Sun Yat-sen University Cancer Center (current role).

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Desheng Weng’s clinical-research focus centers on immunotherapy and biotherapy for melanoma and sarcoma, supported by cancer genetics work.

Cancer immunotherapy as a comprehensive treatment approach.
Cancer genetics research, including tumor suppressor gene expression studies (ING2, TESTIN, BATF2, LZAP, BIN1).
Functional evaluation using in vitro proliferation, clone formation, motility, invasion, and apoptosis assays.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

Publication and citation metrics are not specified in the provided profile materials.

Courses and advanced training

Courses and advanced training are not specified in the provided profile materials.

Awards and recognition

Awards are not specified in the provided profile materials.

Desheng Weng’s role at Sun Yat-sen University Cancer Center places him within a biotherapy and immunotherapy environment for melanoma and sarcoma. The profile materials do not specify spoken languages.